Results 11 to 20 of about 4,504 (155)

Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections [PDF]

open access: yesDrug Design, Development and Therapy, 2010
Emily Zoller, Connie Valente, Kyle Baker, Michael E KlepserFerris State University College of Pharmacy, Kalamazoo, Michigan, USAAbstract: Posaconazole is an extended-spectrum azole antifungal that exhibits activity against a broad range of fungal ...
Emily Zoller   +3 more
doaj   +2 more sources

Mineralocorticoid hypertension and hypokalaemia induced by posaconazole

open access: yesEcho Research and Practice, 2018
We describe severe hypokalaemia and hypertension due to a mineralocorticoid effect in a patient with myelodysplastic syndrome taking posaconazole as antifungal prophylaxis.
Charlotte Boughton   +4 more
doaj   +2 more sources

Posaconazole treatment of refractory coccidioidomycosis in dogs

open access: yesJournal of Veterinary Internal Medicine, 2021
Background The majority of dogs with coccidioidomycosis recover with administration of fluconazole or itraconazole, although some cases are refractory or the dogs do not tolerate administration of these medications.
Lisa F. Shubitz   +4 more
doaj   +2 more sources

Posaconazole: A Review of Drug Interactions with HIV Antiretroviral Agents

open access: yesPharmacy, 2014
The purpose of this review is to examine the literature for reports of clinically significant interactions noted amongst HIV antiretroviral medications when coadministered with posaconazole.
Mara Poulakos, Amy Henneman, Simon Leung
doaj   +2 more sources

Pharmacokinetics and safety of posaconazole delayed-release tablets for invasive fungal infections

open access: yesClinical Pharmacology: Advances and Applications, 2015
Nathan P Wiederhold Departments of Pathology and Medicine/Infectious Diseases, University of Texas Health Science Center at San Antonio, South Texas Reference Laboratories, San Antonio, TX, USA Abstract: Posaconazole is a broad-spectrum triazole ...
Wiederhold NP
doaj   +1 more source

CAQ Corner: Basic concepts of transplant immunology

open access: yes, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

Impact of glucuronide interferences on therapeutic drug monitoring of posaconazole by tandem mass spectrometry [PDF]

open access: yes, 2010
Background: Posaconazole is a novel antifungal drug for oral application intended especially for therapy of invasive mycoses. Due to variable gastrointestinal absorption, adverse side effects, and suspected drug-drug interactions, therapeutic drug ...
Michael Vogeser   +9 more
core   +1 more source

Posaconazole Serum Drug Levels Associated With Pseudohyperaldosteronism [PDF]

open access: yes, 2020
Posaconazole tablets are well tolerated and efficacious in the prophylaxis and treatment of aspergillosis, mucormycosis, and other invasive fungal infections.
Wittenberg, Rebecca   +12 more
core   +1 more source

THE EFFICACY OF POSACONAZOLE FOR PROPHYLAXIS OF INVASIVE MYCOSES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

open access: yesМедицинский совет, 2017
Efficacy of posaconazole for prophylaxis was evaluated in 77 chemotherapy cycles in 59 patients with acute myeloid leukemia (AML) aged 39 (17–62) years from 2012  till 2017.
G. A. Klyasova   +5 more
doaj   +1 more source

732. Posaconazole Serum Drug Levels Associated with Pseudohyperaldosteronism [PDF]

open access: yes, 2019
Background Posaconazole is an extended-spectrum triazole used in the treatment and prophylaxis of many fungal diseases. There have been case reports of posaconazole-induced pseudohyperaldosteronism; however, its occurrence and ...
Wittenberg, Rebecca   +7 more
core   +3 more sources

Home - About - Disclaimer - Privacy